Georges Simon
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Intensive Care Unit Cognitive Disorders
Papers in
-
- Intensive Care Unit Cognitive Disorders 4
-
- SARS-CoV-2 and COVID-19 Research 2
- Antimicrobial Resistance in Staphylococcus 1
- Co-authors
- Clarence Eloy (1 shared paper)Vincent Legros (1 shared paper)Lukshe Kanagaratnam (1 shared paper)Antoine Goury (1 shared paper)Vincent Castelain (1 shared paper)
- Journals
- The Lancet (6 papers)Critical Care (2 papers)Intensive Care Medicine (2 papers)Health and Quality of Life Outcomes (1 paper)JAMA (1 paper)
- Partner nations
- FranceAustraliaUnited Kingdom
In The Last Decade
Georges Simon
15 papers receiving 1.7k citations
Georges Simon's Hit Papers
Peers
Comparison fields: 5 of 102
- Infectious Diseases 961
- Critical Care and Intensive Care Medicine 172
- Applied Microbiology and Biotechnology 50
- Neurology 348
- Internal Medicine 56
Countries citing papers authored by Georges Simon
This map shows the geographic impact of Georges Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georges Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georges Simon more than expected).
Fields of papers citing papers by Georges Simon
This network shows the impact of papers produced by Georges Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georges Simon. The network helps show where Georges Simon may publish in the future.
Co-authors
The 5 scholars most cited alongside Georges Simon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 5 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 6 | 2019 | 118 | |
| 7 | 2023 | 83 | |
| 8 | 2017 | 30 | |
| 9 | 2019 | 25 | |
| 10 | 2017 | 23 | |
| 11 | 2020 | 15 | |
| 12 | 2007 | 9 | |
| 13 | 2023 | 7 | |
| 14 | 2024 | 3 | |
| 15 | 2025 | 1 | |
| 16 | 2026 | 0 |
About Georges Simon
Georges Simon is a scholar working on Critical Care and Intensive Care Medicine, Infectious Diseases, Molecular Medicine, Clinical Biochemistry and Public Health, Environmental and Occupational Health, having authored 16 papers that have together received 1.8k indexed citations. Recurring topics across this work include Intensive Care Unit Cognitive Disorders (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Antibiotic Resistance in Bacteria (1 paper), Palliative Care and End-of-Life Issues (1 paper), Antimicrobial Resistance in Staphylococcus (1 paper) and Bacterial Identification and Susceptibility Testing (1 paper). The work is most often cited by research in Infectious Diseases (961 citations), Critical Care and Intensive Care Medicine (172 citations), Applied Microbiology and Biotechnology (50 citations), Neurology (348 citations) and Internal Medicine (56 citations). Georges Simon has collaborated with scholars based in France, Australia and United Kingdom. Frequent co-authors include Clarence Eloy, Vincent Legros, Lukshe Kanagaratnam, Antoine Goury and Vincent Castelain. Their work appears in journals such as The Lancet, Critical Care, Intensive Care Medicine, Health and Quality of Life Outcomes and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.